Gene,Genotype(s),Therapeutic Area(s),Drug(s)
CYP3A5,*1/*1,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
CYP3A5,*1/*3,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
CYP3A5,*1/*6,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
CYP3A5,*1/*7,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
CYP3A5,*1/*8,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
CYP3A5,*1/*9,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,tacrolimus
